Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Instructions foronline consultation
Reduced caloric intake resulting from appetite suppression may initially cause feelings of low energy, particularly if patients are not consuming adequate nutrition
CT-388 is also being investigated in an additional phase II study (CT388-104) to evaluate CT-388 in obesity or those with excess weight and have type 2 diabetes
This product is not an approved pharmaceutical and is not the medication associated with any branded product
Ongoing studies are exploring Tirzepatides potential benefits beyond diabetes and weight management
US$ 20.27
US$ 24.27
US$ 22.47
US$ 29.17
US$ 29.15
US$ 22.07
US$ 25.57
US$ 25.85
US$ 25.04
US$ 25.86
US$ 26.33
